Development of Advanced Bioimpedance Devices Driving Global Bioimpedance Devices Market

Global bioimpedance device market is anticipated to grow at a CAGR of 9.6% during the forecast period (2024-2031). The ongoing development of advanced bioimpedance devices to meet the customer’s demand is a key factor driving the global bioimpedance market. 

Browse the full report description of “Bioimpedance Device Market Size, Share & Trends Analysis Report by Product Type (Single-Frequency Bioimpedance Devices, and Multiple-Frequency Bioimpedance Devices), by Modality (Wired Bioimpedance Devices, and Wireless Bioimpedance Devices), and by End-Users (Hospitals, Specialty Clinics, Rehabilitation Centers, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/bioimpedance-device-market

Few Recent Advancements-

• In March 2024, InBody launched the Next-Generation Body Composition Analyzers. Introduction of the InBody 380 and InBody 580 devices, redefining health, and fitness measurement. 

• In March 2024, Xiaomi’s smart body scale goes global. It has 25 health metrics at an affordable price. The Mijia S400 smart scale is coming to the global market under the name Xiaomi Body Composition Scale S400. It also provides various health indicators such as heart rate, body mass index (BMI), body water mass, fat mass, body fat percentage, and muscle mass. Moreover, Xiaomi is gearing up to offer this smart scale, capable of all these measurements, at an incredibly low price.

• In June 2023, the GlucoRX BioXensor used multiple built-in sensors to provide real-time blood glucose readings while tracking heart rate, temperature, and movement. GlucoRX, a diabetes supply company with one industry leading CGM, has recently unveiled the next CGM which is yet to be approved. The BioXensor is the first CGM in the world to utilize multiple sensor types to provide real-time blood glucose readings.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Product Type

o By Modality

o By End-Users

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Inbody Co., Ltd., General Electric Company, Omron Corp., Fresenius Medical Care and ImpediMed Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Bioimpedance Device Market Report Segment

By Product Type

• Single-Frequency Bioimpedance Devices
• Multiple-Frequency Bioimpedance Devices

By Modality

• Wired Bioimpedance Devices
• Wireless Bioimpedance Devices

By End-Users

• Hospitals
• Specialty Clinics
• Rehabilitation Centers
• Others (Ambulatory Surgical Center)

Global Bioimpedance Device Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioimpedance-device-market